Efficacy of m-Health for the detection of adverse events following immunization – The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial-Reference-Cited by-同舟云学术

Efficacy of m-Health for the detection of adverse events following immunization – The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial

Published:2021-01 Issue:2 Volume:39 Page:332-342
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gold M.S.,Lincoln G.,Cashman P.,Braunack-Mayer A.,Stocks N.

Funder

Sanofi Pasteur

GlaxoSmithKline

Department of Human Services, Government of South Australia

Department of Health, State Government of Victoria

Department of Health, Government of Western Australia

National Health and Medical Research Council

University of Adelaide

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Shameer A. World Health Organisation Global vaccine Safety Blueprint. https://www.who.int/docs/default-source/documents/global-vaccine-safety-blueprint-1-2012.pdf (accessed 6/5/20)

2. Factors That Influence the Implementation of E-Health: A Systematic Review of Systematic Reviews (An Update);Stevenson;Implement Sci,2016

3. Can Digital Tools Be Used for Improving Immunization Programs?;Tozzi;Front Public Health,2016

4. Heininger U, Holm K, Caplanusi I et al Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety – executive summary Vaccine 20187 35:3917-3921

5. Influence of physicians’ attitudes on reporting adverse drug events: a case-control study;Figueiras;Med Care,1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial;Vaccine;2023-10

2. Pharmacovigilance Through Phased Clinical Trials, Post-Marketing Surveillance and Ongoing Life Cycle Safety;The Quintessence of Basic and Clinical Research and Scientific Publishing;2023

3. A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study;JMIR Human Factors;2022-11-04

4. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study;Vaccine;2022-07

5. How Can Mobile Health Technology Improve Usage and Delivery of the COVID-19 Vaccine in Low- and Middle-Income Countries?;Open Access Macedonian Journal of Medical Sciences;2022-04-05